Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sigyn Therapeutics, Inc. (RGNP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Nov-30-16Dec-31-15
   S-1/A10-K10-K10-K10-K10-K10-K/A10-K/A
Revenues  0.00.00.00.10.00.01.63.3
            Revenue growth    -100.0%405.6%-26.2%  7517.0%
Cost of goods sold  0.00.00.00.00.00.00.71.4
Gross profit  0.00.00.00.10.00.00.81.8
            Gross margin     75.1%65.7%44.2%53.8%56.1%
Selling, general and administrative   [+]1.51.30.50.60.91.10.30.8
Research and development  0.70.70.4     
Other operating expenses     -0.2-0.80.91.01.8
EBITDA   [+]-2.1-2.0-0.9-0.20.2-1.8-0.4-0.7
            EBITDA margin     -142.6%654.1%-4663.9%-23.8%-19.8%
Depreciation  0.00.00.00.00.00.00.10.1
EBITA  -2.1-2.0-0.9-0.20.2-1.8-0.4-0.7
            EBITA margin     -151.2%609.3%-4699.6%-28.3%-21.5%
Amortization of intangibles  0.00.00.00.10.20.20.10.0
EBIT   [+]-2.1-2.0-0.9-0.3-0.1-2.0-0.5-0.7
            EBIT margin     -195.1%-218.6%-5277.4%-32.3%-22.8%
Non-recurring items   [+]   0.20.9   
Interest expense  0.00.0 0.10.40.80.10.1
Other income (expense), net   [+]-0.8-1.0-0.3-2.7-0.9-1.0  
Pre-tax income  -2.9-3.0-1.3-3.3-2.3-3.8-0.6-0.8
Income taxes  0.00.00.0-0.20.00.00.00.0
            Tax rate  0.0%0.0%0.0%7.2%  0.0%0.0%
Earnings from continuing ops  -2.9-3.0-1.3-3.3-2.3-3.8-0.6-0.8
Earnings from discontinued ops     0.3-0.3-0.4  
Net income  -2.9-3.0-1.3-3.1-2.6-4.3-0.6-0.8
            Net margin     -2145.3%-9243.2%-11061.2%-40.7%-24.4%
   
Basic EPS   [+]($0.08)($0.08)($0.17)($0.04)($0.04)($0.08)($0.06)($0.08)
Diluted EPS   [+]($0.08)($0.08)($0.17)($0.04)($0.04)($0.08)($0.06)($0.08)
   
Shares outstanding (basic)   [+]37.436.47.481.365.147.110.09.8
Shares outstanding (diluted)   [+]37.436.47.481.365.147.110.09.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy